Sales reported at Rs 0.05 crore
Net loss of Transgene Biotek reported to Rs 0.43 crore in the quarter ended June 2025 as against net profit of Rs 0.20 crore during the previous quarter ended June 2024. Sales remain constant at Rs 0.05 crore in the quarter ended June 2025 and also during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales0.050.05 0 OPM %-280.00-820.00 -PBDT-0.380.22 PL PBT-0.430.20 PL NP-0.430.20 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
